2001
DOI: 10.1016/s0008-6363(00)00241-8
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial pathology in cardiac failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
72
0
3

Year Published

2003
2003
2018
2018

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 122 publications
(79 citation statements)
references
References 104 publications
4
72
0
3
Order By: Relevance
“…From the results presented here, we speculate that mitochondrial dysfunction in heart failure (Marin-Garcia et al, 2001) produces an inward-rectifier K ϩ -channel inhibitor that is responsible for reducing the cardiac inward-rectifier current (Beuckelmann et al, 1993;Kaab et al, 1996;Lodge and Normandin, 1997;Han et al, 2001), thereby contributing to an increased risk of arrhythmia (Pogwizd et al, 2001). Furthermore, we speculate that the inhibitor bears a positive charge, because the presence of a positive charge in or near the binding site would be expected to decrease the affinity of the channel for the positively charged moiety of the inhibitory ligand.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…From the results presented here, we speculate that mitochondrial dysfunction in heart failure (Marin-Garcia et al, 2001) produces an inward-rectifier K ϩ -channel inhibitor that is responsible for reducing the cardiac inward-rectifier current (Beuckelmann et al, 1993;Kaab et al, 1996;Lodge and Normandin, 1997;Han et al, 2001), thereby contributing to an increased risk of arrhythmia (Pogwizd et al, 2001). Furthermore, we speculate that the inhibitor bears a positive charge, because the presence of a positive charge in or near the binding site would be expected to decrease the affinity of the channel for the positively charged moiety of the inhibitory ligand.…”
Section: Discussionmentioning
confidence: 93%
“…Mitochondrial dysfunction is increasingly recognized as an important aspect of the pathophysiology of several neurological and cardiovascular disorders, including Alzheimer's disease (Baloyannis et al, 2004), Parkinson's disease (Fiskum et al, 2003), heart failure (Marin-Garcia et al, 2001), myocardial and cerebral ischemia (Sims and Anderson, 2002;Sadek et al, 2003), and, potentially, epilepsy (Patel, 2002). Alteration of electrical excitability is central to many of these diseases, leading to either neuronal excitotoxicity or cardiac arrhythmia (Doble, 1999;Janse, 2004).…”
mentioning
confidence: 99%
“…In two studies with humans and one study with mice, we found this mutation to predominate, representing from 55 to 62 percent of total mutations seen in the three studies (11,12,13). Thus, it appears likely that natural mitochondrial dNTP asymmetry, at least in heart and skeletal muscle, influences the spontaneous mutation rate and spectrum.…”
Section: Stimulation Of Mitochondrial Mutagenesis By Dntp Pool Imbalancementioning
confidence: 77%
“…Independent of the heart failure stage, changes in mitochondrial electron transport chain components were described [134][135][136][137]. Indeed, the progressive decrease of ATP production is linked to both a decrease of fatty acid oxidation and a reduction of mitochondrial respiration due to electron transport chain defects [138].…”
Section: Heart and Oxidative Stressmentioning
confidence: 99%